New York: A prominent Indian-American doctor and his wife have agreed to pay USD 1.2 million to settle allegations of prescribing unapproved drugs in the US.
The couple allegedly profited by administering the cheaper unapproved drugs, the Department of Justice said.
They will pay USD 1.2 million to resolve state and federal False Claims Act allegations that their medical practice billed Medicare and Tennessee Medicaid for anti- cancer and infusion drugs that were produced for sale in foreign countries and not approved by the Food and Drug Administration (FDA) for marketing in the US, it said.
“Billing for foreign drugs that are not approved by the FDA undermines federal healthcare programmes and could potentially risk patient safety,” said Acting Assistant Attorney General Chad Readler of the Justice Departments Civil Division.
The government alleged that the unapproved drugs that the Sens provided to patients and billed to Medicare were not reimbursable under those programmes.
It is further alleged that the Sens purchased unapproved drugs because they were less expensive than the drugs approved by FDA for marketing in the US.
Claims settled by this agreement are allegations only and there has been no determination of liability, the Justice Department added.